{"id":"W4391815864","doi":"10.1186/s13023-024-03059-3","title":"EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders","year":2024,"lang":"en","type":"review","venue":"Orphanet Journal of Rare Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Novartis Pharma; Prinses Beatrix Spierfonds; Ataxia UK; Argenx; Alexion Pharmaceuticals; E-Rare; Cytokinetics; Amicus Therapeutics; CSL Behring; Medical Research Council; AveXis; Biogen; European Commission; Sanofi; Third Health Programme; Ipsen; Alnylam Pharmaceuticals; Italfarmaco; Wellcome Trust; Ministero della Salute; Pfizer","keywords":"Disease registry; Interoperability; Patient registry; Medicine; Neuromuscular disease; Health information exchange; European commission; Business; Disease; Computer science; Health care; Family medicine; Pathology; World Wide Web; Pediatrics; Political science; European union","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006036522,0.0006550557,0.002464406,0.0004949408,0.00009295945,0.0001005653,0.0003236496,0.0003550989,0.00003881658],"category_scores_gemma":[0.00126065,0.0004389581,0.0007220155,0.000863425,0.0004292295,0.0001219613,0.0001515119,0.0006682778,0.00000137892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007265502,"about_ca_system_score_gemma":0.0009565676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003706892,"about_ca_topic_score_gemma":0.000001135305,"domain_scores_codex":[0.9972366,0.0001275882,0.001323893,0.0004733405,0.0004919498,0.0003466132],"domain_scores_gemma":[0.9965399,0.0001896146,0.001947018,0.0004356549,0.0006826273,0.0002051884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006639638,0.0002538893,0.0004412077,0.04876128,0.001953594,0.00157426,0.000192907,0.000001375627,0.00001418437,0.0002341959,0.02912472,0.9167844],"study_design_scores_gemma":[0.001891398,0.001539671,0.0001088235,0.0328978,0.005018362,0.001805006,0.002296823,0.000006093258,0.00002220212,0.0007301584,0.9532226,0.0004610091],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002875782,0.9933723,0.00002532608,0.0001881659,0.0003595485,0.001237998,0.001819474,0.00007568359,0.00004569943],"genre_scores_gemma":[0.0252818,0.9733351,0.0002248398,0.00005123142,0.0001499042,0.00004293194,0.0006982643,0.0001147863,0.0001011782],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.924098,"threshold_uncertainty_score":0.9998062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660152034423282,"score_gpt":0.2963952726096451,"score_spread":0.2797937522654123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}